InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+12.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Broadfoot Jill Marie, 首席财务官. Insider active across 4 companies, notably Acelrx Pharmaceuticals INC. In total, 12 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €20k. History available since 20 November 2021. The latest transaction was disclosed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Broadfoot Jill Marie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
5,100 股Common StockSEC:0001305178-26-000002:0
3,750 股Common StockSEC:0001193125-26-038002:0
4,267 股0Common StockSEC:0001305178-25-000004:0
3,750 股Common StockSEC:0000950170-25-013884:0
2,174 股0Common StockSEC:0001415889-24-018073:0
5,000 股@ US$1.7942.1% 占其流量Common StockSEC:0000950170-24-067668:0
标准退出：2024年8月29日 (T+90)
3,750 股Common stockSEC:0001209191-24-002947:0
581 股0Common StockSEC:0001209191-23-058479:0
3,750 股Common stockSEC:0001209191-23-007364:0
15,500 股0Common StockSEC:0001209191-22-042311:0
1,923 股@ US$6.7557.9% 占其流量Common stockSEC:0001209191-22-003419:0
标准退出：2022年4月13日 (T+90)
15,000 股0Common StockSEC:0001209191-21-066559:0
12 条申报中的 12 条
About Broadfoot Jill Marie
Broadfoot Jill Marie is Directeur Financier and holds roles at aTYR PHARMA INC, TALPHERA, INC., and Acelrx Pharmaceuticals INC. She has 12 filings in total, and across the 12 sampled recent filings between 2021-11-23 and 2026-06-24, buys amount to EUR 19605, with no sells, and the most frequent transaction nature is Attribution.
